Experience

Edesa Biotech Inc. closes US$3 million private placement

Reading Time 1 minute read
Share

Overview

Client

Edesa Biotech, Inc.

On November 3, 2022, Edesa Biotech Inc., a Canadian clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, completed a US$3 million private placement of units, priced at-the-market.

Fasken acted for Edesa Biotech Inc., with a team led by Wojtek Baraniak and Myroslav Chwaluk, and which included Alexis Shamess and Arjun Sodhi (Articling Student).

Jurisdiction

  • Ontario

Team

  • A. Wojtek Baraniak, Partner | Mergers & Acquisitions, Toronto, ON, +1 416 868 3332, [email protected]
  • Myroslav Chwaluk, Partner | Capital Markets, Toronto, ON, +1 416 868 3413, [email protected]
  • Arjun Sodhi, Associate | Mergers & Acquisitions, Vancouver, BC, +1 604 631 3127, [email protected]
A. Wojtek Baraniak Toronto Lawyer A. Wojtek Baraniak Partner | Mergers & Acquisitions Toronto, ON +1 416 868 3332
Myroslav Chwaluk Toronto Lawyer Myroslav Chwaluk Partner | Capital Markets Toronto, ON +1 416 868 3413
Arjun Sodhi Articling Student in Toronto Arjun Sodhi Associate | Mergers & Acquisitions Vancouver, BC +1 604 631 3127